GlassScriptPhysician profile
Robert E Federici
NPI 1053315390
$77,045.84
in general payments reported to CMS, 2019-2025
28 companies · $1,240 in 2025
The $1,240 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $17K · 2021: $24K · 2022: $7,598 · 2023: $11K · 2024: $1,256 · 2025: $1,240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,200 · Food and Beverage: $5,088 · Travel and Lodging: $1,655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,200.00 |
| Food and Beverage | $5,088.25 |
| Travel and Lodging | $1,655.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $39,674.04 | 2019-2024 | Impella |
| Boston Scientific Corporation | $31,340.80 | 2019-2025 | Watchman Access System, Watchman, Avvigo Guidance System |
| Medtronic, INC. | $1,855.83 | 2021-2025 | Endurant Iis, Onyx Frontier, Micra |
| Medtronic Vascular, INC. | $892.92 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $422.06 | 2019-2025 | |
| Abbott Laboratories | $372.33 | 2019-2025 | Amplatzer Amulet, Mitraclip |
| Philips North America LLC | $371.54 | 2019-2023 | |
| Amgen INC. | $337.81 | 2019-2025 | Repatha, Repatha |
| Heartflow, INC. | $310.58 | 2025 | |
| Cvrx, INC. | $257.08 | 2022-2023 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $199.29 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $143.33 | 2021-2023 | Xarelto |
| Asahi Intecc USA, INC. | $124.64 | 2019 | |
| Cardiovascular Systems INC. | $115.59 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $107.04 | 2019-2024 | Farxiga |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.49 | 2019-2024 | Lifevest |
| Pfizer INC. | $79.60 | 2020-2024 | |
| Shockwave Medical, INC | $70.38 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $54.23 | 2025 | Hillrom - Carnation Ambulatory Monitor, Perclot |
| Ge Healthcare | $35.55 | 2023 | |
| Cardiva Medical, INC. | $34.72 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Inari Medical, INC. | $29.27 | 2022 | |
| Teleflex LLC | $28.55 | 2025 | Guideliner |
| Surmodics, INC. | $24.08 | 2023 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Actelion Pharmaceuticals US, INC. | $23.43 | 2025 | Opsumit |
| Merck Sharp & Dohme LLC | $17.31 | 2023 | Verquvo |
| Cook Medical LLC | $13.75 | 2019 | |
| Bard Peripheral Vascular, INC. | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Federici listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.